Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation

Cellular Microbiology

Volumn 10, Issue 8, 2008, Pages 1622-1633

  Alvarez, Mauricio ^a   Saylor, Carolyn ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL POLYSACCHARIDE;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOFILM; CELL DIVISION; COLONY FORMATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; EXOCYTOSIS; FUNGAL CELL; HOST CELL; HOST PATHOGEN INTERACTION; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; BIOFILMS; CELL LINE; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; EXOCYTOSIS; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; PHAGOCYTOSIS; PHAGOSOMES;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 47549088472     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01152.x     Document Type: Article

References (38)

1. Alvarez, M., and Casadevall, A. (2006) Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 16: 2161-2165.
2. Alvarez, M., and Casadevall, A. (2007) Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol 8: 16.
3. Baro, T., Torres-Rodriguez, J.M., De Mendoza, M.H., Morera, Y., and Alia, C. (1998) First identification of autochthonous Cryptococcus neoformans var. gattii isloated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 36: 458-461.
4. Campbell, L.T., Fraser, J.A., Nichols, C.B., Dietrich, F.S., Carter, D., and Heitman, J. (2005) Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell 4: 1410-1419.
5. Casadevall, A., and Perfect, J. (1998) Cryptococcus Neoformans. Washington, DC: American Society for Microbiology Press.
6. Casadevall, A., Mukherjee, J., Devi, S.J., Schneerson, R., Robbins, J.B., and Scharff, M.D. (1992) Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 165: 1086-1093.
7. Chen, S., Sorrell, T., Nimmo, G., Speed, B., Currie, B., Ellis, D., et al. (2000) Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 31: 499-508.
8. Cherniak, R., Morris, L.C., Belay, T., Spitzer, E.D., and Casadevall, A. (1995) Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun 63: 1899-1905.
9. Fan, W., Kraus, P.R., Boily, M.J., and Heitman, J. (2005) Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot Cell 4: 1420-1433.
10. Feldmesser, M., Kress, Y., Novikoff, P., and Casadevall, A. (2000) Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68: 4225-4237.
11. Feldmesser, M., Tucker, S., and Casadevall, A. (2001) Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 9: 273-278.
12. Fisher, D., Burrow, J., Lo, D., and Currie, B. (1993) Cryptococcus neoformans in tropical northern Australia: Predominantly variant gattii with good outcomes. Aust N Z J Med 23: 678-682.
13. Gangadharam, P.R., and Pratt, P.F. (1983) In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium intracellulare. Am Rev Respir Dis 128: 1044-1047.
14. Hoang, L.M., Maguire, J.A., Doyle, P., Fyfe, M., and Roscoe, D.L. (2004) Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): Epidemiology, microbiology and histopathology. J Med Microbiol 53: 935-940.
15. Kelly, R.M., Chen, J., Yauch, L.E., and Levitz, S.M. (2005) Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun 73: 592-598.
16. Kohut, M.L., Senchina, D.S., Madden, K.S., Martin, A.E., Felten, D.L., and Moynihan, J.A. (2004) Age effects on macrophage function vary by tissue site, nature of stimulant, and exercise behavior. Exp Gerontol 39: 1347-1360.
17. Kozel, T.R. (1993) Opsonization and phagocytosis of Cryptococcus neoformans. Arch Med Res 24: 211-218.
18. Kozel, T.R., Pfrommer, G.S., Guerlain, A.S., Highison, B.A., and Highison, G.J. (1988) Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis 10 (Suppl. 2): S436-S439.
19. Li, L., Zaragoza, O., Casadevall, A., and Fries, B.C. (2006) Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cell Microbiol 8: 1730-1739.
20. Ma, H., Croudace, J.E., Lammas, D.A., and May, R.C. (2006) Expulsion of live pathogenic yeast by macrophages. Curr Biol 16: 2156-2160.
21. Macura, N., Zhang, T., and Casadevall, A. (2007) Dependence of macrophage phagocytic efficacy on antibody concentration. Infect Immun 75: 1904-1915.
22. Mukherjee, J., Casadevall, A., and Scharff, M.D. (1993) Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 177: 1105-1116.
23. Mukherjee, J., Nussbaum, G., Scharff, M.D., and Casadevall, A. (1995a) Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med 181: 405-409.
24. Mukherjee, S., Lee, S.C., and Casadevall, A. (1995b) Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 63: 573-579.
25. Narasipura, S.D., Ault, J.G., Behr, M.J., Chaturvedi, V., and Chaturvedi, S. (2003) Characterization of Cu,Zn superoxide dismutase (SOD1) gene knock-out mutant of Cryptococcus neoformans var. gattii: role in biology and virulence. Mol Microbiol 47: 1681-1694.
26. Netski, D., and Kozel, T.R. (2002) Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: Importance of epitope specificity. Infect Immun 70: 2812-2819.
27. Pierini, L.M., and Doering, T.L. (2001) Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol Microbiol 41: 105-115.
28. Ralph, P., Prichard, J., and Cohn, M. (1975) Reticulum cell sarcoma: An effector cell in antibody-dependent cell-mediated immunity. J Immunol 114: 898-905.
29. Raso, T.F., Werther, K., Miranda, E.T., and Mendes-Giannini, M.J. (2004) Cryptococcosis outbreak in psittacine birds in Brazil. Med Mycol 42: 355-362.
30. Ren, P., Roncaglia, P., Springer, D.J., Fan, J., and Chaturvedi, V. (2005) Genomic organization and expression of 23 new genes from MATalpha locus of Cryptococcus neoformans var. gattii. Biochem Biophys Res Commun 326: 233-241.
31. Steenbergen, J.N., Shuman, H.A., and Casadevall, A. (2001) Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA 98: 15245-15250.
32. Sugar, A.M., Brummer, E., and Stevens, D.A. (1986) Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis. J Med Microbiol 21: 7-11.
33. Taborda, C.P., and Casadevall, A. (2002) CR3 (CD11b/CD18) and CR4 (CD11c/ CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16: 791-802.
34. Taylor, M.B., Chadwick, D., and Barkham, T. (2002) First reported isolation of Cryptococcus neoformans var. gattii from a patient in Singapore. J Clin Microbiol 40: 3098-3099.
35. Tucker, S.C., and Casadevall, A. (2002) Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci USA 99: 3165-3170.
36. Xu, J., Vilgalys, R., and Mitchell, T.G. (2000) Multiple gene genealogies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans. Mol Ecol 9: 1471-1481.
37. Yuan, R., Casadevall, A., Spira, G., and Scharff, M.D. (1995) Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol 154: 1810-1816.
38. Zaragoza, O., Taborda, C.P., and Casadevall, A. (2003) The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol 33: 1957-1967.